Summary
64 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 6.3% a year over the last 3 years.
- It earns 8.7 THB a year on every 100 THB of invested capital.
What to watch
- Repaying its net debt would take 5.3 years of operating profit.
- It reports a profit, yet spends more cash than it brings in.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.0 THB for 1 THB of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (THB)
Diluted EPS (THB)
- Analyst estimate
Revenue grew by 13% a year over 5 years. Over the last 3 years it grew by 6.3% a year. Earnings per share grew by 2.4% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 THB of revenue goes
- Cost of sales 91 THB
- Sales and administration 2.5 THB
- Taxes and other 1.5 THB
- Net profit 5.0 THB
Net profit, industry median (Chemicals - Specialty) 6.1 THB
Out of every 100 THB of revenue, 5.0 THB is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 1.08%
- Paid out of profit
- 6.5%
You receive ฿0.05 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail